DENVER, Sept. 15 Corgenix Medical Corporation(OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostictest kits, will host a conference call on Thursday, September 25, 2008, at4:00 PM EDT to discuss the Company's financial and operating performance forits fiscal year ended June 30, 2008, and the status of the Company's productdevelopment and marketing activities.
Corgenix invites all those interested in hearing management's discussionof the annual results to join the call by dialing:
A question-and-answer session will follow the presentation by Corgenixmanagement.
A replay will be available for 30 days following the call by dialing (800)374-0934 for US participants and +1 402 220 0680 for internationalparticipants.
About Corgenix Medical Corporation
Corgenix is a leader in the development and manufacturing of specializeddiagnostic kits for immunology disorders, vascular diseases and bone and jointdisorders, including the world's only non-blood-based test for aspirinnon-responsiveness. Corgenix diagnostic products are commercialized for use inclinical laboratories throughout the world. The company currently sells over50 diagnostic products through a global distribution network and hassignificant experience advancing products through the FDA process. Moreinformation is available at http://www.corgenix.com.US attendees: (800) 894-5910 International attendees: +1 785 424 1052 Conference code is: CORGENIX
SOURCE Corgenix Medical Corporation